Development of an on-site rapid test for the detection of SARS-CoV-2 antigenes for the Charité Berlin

Key facts

Disease
COVID-19
Start & end year
2020
2021
Known Financial Commitments (USD)
$31,959.25
Funder
Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)
Principal Investigator
Pending
Research Location
Germany
Lead Research Institution
Fassisi mbH, Göttingen
Research Priority Alignment
N/A

Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified

Abstract: The aim of the project is to prepare an on-site rapid test for the specific detection of SARS-CoV-2 based on the preparatory work of the project "SARS-MAB - Generation of murine, monoclonal antibodies against SARS-CoV-2" (UPK GmbH). Developed patient samples will be made available to Charité (AG Dr. Corman).The planned test procedure can form the basis for further research into the virus and the course of the disease and could possibly also be used in diagnostic procedures.; Research Type: discovery; Study population: not applicable